Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: Correlation with clinical outcome after traumatic brain injury

American Journal of Neuroradiology

Volumn 22, Issue 1, 2001, Pages 143-151

  Sinson, G ^a   Bagley, L J ^a   Cecil, K M ^a   Torchia, M ^a   McGowan, J C ^a   Lenkinski, R E ^a   McIntosh, T K ^a   Grossman, R I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; AXONAL INJURY; BRAIN INJURY; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; GLASGOW COMA SCALE; HUMAN; MALE; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ASPARTIC ACID; AXONS; BIOLOGICAL MARKERS; BRAIN; BRAIN INJURIES; BRAIN STEM; CORPUS CALLOSUM; CREATINE; GLASGOW COMA SCALE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; TIME FACTORS;

EID: 0035144968     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Types of injuries by selected characteristics: United States
2. Epidemiology of brain injury
3. Traumatic brain injuries: Predictive usefulness of CT
4. Neuropsychological outcome and quantitative image analysis of acute haemorrhage in traumatic brain injury: Preliminary findings
5. Effects of acute injury characteristics on neurophysical status and vocational outcome following mild traumatic brain injury
6. Improved confidence of outcome prediction in severe head injury: A comparative analysis of the clinical examination, multimodality evoked potentials, CT scanning, and intracranial pressure
7. The prognostic value of the Glasgow Coma Scale, hypoxia and computerised tomography in outcome prediction of pediatric head injury
8. Prognostic value of the amount of post-traumatic subarachnoid haemorrhage in a six month follow up period
9. The Westmead Head Injury Project outcome in severe head injury: A comparative analysis of pre-hospital, clinical and CT variables
10. Absent or compressed basal cisterns on first CT scan: Ominous predictors of outcome in severe head injury
11. The prognostic value of computerized tomography in comatose head-injured patients
12. Computed tomography and magnetic resonance imaging in mild to moderate head injury: Early and late imaging related to outcome
13. Outcome from severe head injury related to the type of intracranial lesion: A computerized tomography study
14. Predicting survival using simple clinical variables: A case study in traumatic brain injury
15. Comparative use of magnetic resonance imaging and electrophysiologic investigation for the prognosis of head injury
16. Early and late magnetic resonance imaging and neuropsychological outcome after head injury
17. Neuropsychological consequences of two patterns of brain damage shown by MRI in survivors of severe head injury
18. Prediction of recovery from post-traumatic vegetative state with cerebral magneticresonance imaging
19. A study comparing SPECT with CT and MRI after closed head injury
20. Proton MR spectroscopy after acute central nervous system injury: Outcome prediction in neonates, infants, and children
21. Neuronal dysfunction in patients with closed head injury evaluated by in vivo 1H magnetic resonance spectroscopy
22. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis
23. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: Correlative findings of active versus irreversible plaque disease
24. Assessment and prognosis of coma after head injury
25. Assessment of outcome after severe brain damage: A practical scale
26. Magnetization transfer imaging of traumatic brain injury
27. Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patients
28. The outcome of severe closed head injury
29. The incidence of acute brain injury and serious impairment in a defined population
30. Disability caused by minor head injury
31. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives
32. Synergistic effects of traumatic head injury and apolipoprotein-e4 in patients with Alzheimer's disease
33. Guidelines for the management of severe head injury
34. Pathophysiology of head injury
35. The neurochemical sequelae of traumatic brain injury: Therapeutic implications
36. Magnetization transfer: Theory and clinical applications in neuroradiology
37. Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging
38. Wallerian degeneration in feline visual system: Characterization with magnetization rate with histopathological correlation
39. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: Characterization by magnetization transfer ratio with histopathologic correlation
40. Diffuse axonal pathology detected with magnetization transfer imaging following brain injury in the pig
41. Assessment of outcome from head injury
42. Magnetization transfer imaging in the detection of injury associated with minor head trauma
43. Relapsing-remitting multiple sclerosis: Longitudinal analysis of MR images: Lack of correlation between changes in T2 lesion volume and clinical findings
44. MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis
45. New aspects of brain physiology
46. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia
47. A relationship of N-acetylaspartate biosynthesis to neuronal protein synthesis
48. Lipogenesis in the brain of suckling rats: Studies on the mechanism of mitochondrial/cytosolic carbon transfer
49. N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain
50. Time dependence of N-acetyl-aspartate, lactate, and pyruvate concentrations following spinal cord injury
51. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy
52. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy
53. Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: A proton MR spectroscopy study
54. Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: A proton magnetic resonance spectroscopy study
55. Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke
56. Proton MR spectroscopy in acute middle cerebral artery stroke
57. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS
58. Evaluation of 1H magnetic resonance spectroscopic imaging as a diagnostic tool for the lateralization of epileptogenic seizure foci
59. Total brain N-acetylaspartate: A new measure of disease load in MS
60. High resolution proton NMR spectroscopy of multiple sclerosis lesions
61. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients
62. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy
63. Axonal transection in the lesions of multiple sclerosis
64. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging
65. Proton magnetic resonance spectroscopy with dementia
66. Proton magnetic resonance spectroscopy in dementia of Alzheimer type
67. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study
68. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease
69. Probable Alzheimer's disease: Diagnosis with proton MR spectroscopy
70. Aizheimer disease: Quantitative H-1 MR spectroscopic imaging of frontoparietal brain
71. A 1H MRS study of probable Alzheimer's disease and normal aging: Implications for longitudinal monitoring of dementia progression
72. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy
73. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging
74. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging
75. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging
76. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy
77. AIDS dementia complex: Evaluation with proton MR spectroscopy imaging
78. N-acetylaspartyl-glutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases
79. N-acetylaspartate and N-acetylaspartylglutamate levels in Alzheimer's disease post-mortem brain tissue
80. Reversible decreases in N-acetylaspartate after acute brain injury
81. Brief report: Organic osmolytes in the brain of an infant with hypernatremia
82. High resolution 1H NMR spectroscopy following experimental brain trauma
83. Reduction of N-acetyl-aspartate is proportional to severity of traumatic brain injury
84. High-field proton magnetic resonance spectroscopy of a swine model for axonal injury
85. Trauma to the corpus callosum: MR features
86. Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions
87. Proton spectroscopy of human brain: Effects of age and sex
88. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium
89. Head injury trials: Past and present
90. Total brain N-acetylaspartate: A new measure of disease load in MS